| [1] | Mestecki J., Strober W., Russell W.M., et al. (2015). Mucosal Immunology, 4th edition. (Elsevier, Academic Press). DOI:10.1016/C2010-1-65194-2 |
| [2] | Kugelberg E., Gollan B. and Tang C.M. (2008). Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing. Vaccine 26:I34−I39. DOI:10.1016/j.vaccine.2008.11.059 |
| [3] | Yao Y., Jeyanathan M., Haddadi S., et al. (2018). Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity. Cell 175:1634−1650. DOI:10.1016/j.cell.2018.09.042 |
| [4] | Comas I., Coscolla M., Luo T., et al. (2013). Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat. Genet. 45:1176−1182. DOI:10.1038/ng.2744 |
| [5] | MacPherson A.J., McCoy K.D., Johansen F.E., et al. (2008). The immune geography of IgA induction and function. Mucosal Immunol. 1:11−22. DOI:10.1038/mi. 2007.6. DOI:10.1038/mi.2007.6 |
| [6] | Koren T., Yifa R., Amer M., et al. (2021). Insular cortex neurons encode and retrieve specific immune responses. Cell 184:5902−5915. DOI:10.1016/j.cell.2021.10.013 |
| [7] | Martinez L., Cords O., Liu Q., et al. (2022). Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. Lancet Glob. Health 10:e1307−e1316. DOI:10.1016/S2214-109X(22)00283-2 |
| [8] | Yang Q., Zhang M., Chen Q., et al. (2020). Characterization of human tissue-resident memory T cells at different infection sites in patients with tuberculosis. J. Immunol. 204:2331−2336. DOI:10.4049/jimmunol.1901326 |
| [9] | Sakai S., Kauffman K.D., Sallin M.A., et al. (2016). CD4 T cell-derived IFN-γ plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease. PLoS Pathog. 12:e1005667. DOI:10.1371/journal.ppat.1005667 |
| [10] | Krishna Prasad G.V.R., Grigsby S.J., Erkenswick G.A., et al. (2025). Macrophage-T cell interactions promote SLAMF1 expression for enhanced TB defense. Nat. Commun. 16:6794. DOI:10.1038/s41467-025-61826-7 |
| [11] | Satti I., Marshall J.L., Harris S.A., et al. (2024). Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naïve adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial. Lancet Infect. Dis. 24:909−921. DOI:10.1016/S1473-3099(24)00143-9 |
| [12] | Tsai C.J.Y., Loh J.M.S., Fujihashi K., et al. (2023). Mucosal vaccination: onward and upward. Expert Rev. Vaccines 22:885−899. DOI:10.1080/14760584.2023.2268724 |
| [13] | Boraschi D., Carsetti R., Chen L., et al. (2025). Advocating mucosal immunization: a global need in a viewpoint from China. The Innovation 6:100951. DOI:10.1016/j.xinn.2025.100951 |
| Boraschi D., Marques-Neto L., Chen L., et al. (2026). The value of mucosal immunization against bacterial infections: will we conquer tuberculosis in the near future? The Innovation Medicine 4:100180. https://doi.org/10.59717/j.xinn-med.2026.100180 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Mtb infection and vaccine strategies against TB